Outcomes17

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 17 of 17

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Percent Change From Baseline in Surface-to-Curve Ratio (SCR) in the Distal Radius at Month 18 Endpoint	Baseline, 18 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	percent (%) change of ratio	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Surface-to-Curve Ratio (SCR) in the Distal Radius at Month 24 Endpoint	Baseline, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of ratio	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Cortical Thickness (CT) in the Distal Radius at Month 18 and 24 Endpoint	Baseline, 18, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of millimeter (mm)	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Topological Erosion Index (TEI) in the Distal Radius at Month 18 and 24 Endpoint	Baseline, 18, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of ratio	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Bone Volume (BV)/Total Volume (TV) Ratio in the Distal Radius at Month 18 and 24 Endpoint	Baseline, 18, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of ratio	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Surface-to-Curve Ratio (SCR) at Month 3, 6, 12, 18 and 24 Endpoint	Baseline, 3, 6, 12, 18, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of ratio	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Volumetric Bone Mineral Density (BMD) of Lumbar Spine at Month 18 Endpoint	Baseline, 18 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of mg/cm³	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Volumetric Bone Mineral Density (BMD) of Hip at Month 18 Endpoint	Baseline, 18 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of mg/cm³	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in the Estimate of Bone Strength of Lumbar Spine at Month 18 Endpoint	Baseline, 18 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of Newtons	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in the Estimate of Bone Strength of Hip at Month 18 Endpoint	Baseline, 18 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of Newtons	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Areal BMD at the Lumbar Spine at Month 18 and 24 Endpoint	Baseline, 18, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of g/square centimeter (g/cm²)	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Areal BMD at the Femoral Neck at Month 18 and 24 Endpoint	Baseline, 18, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of g/cm²	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Areal BMD Responses at Total Hip at Month 18 and 24 Endpoint	Baseline, 18, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of g/cm²	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Areal BMD at ⅓ Distal Radius at Month 18 and 24 Endpoint	Baseline, 18, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of g/cm²	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Areal BMD at Ultra-Distal Radius at Month 18 and 24 Endpoint	Baseline, 18, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of g/cm²	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Serum Procollagen Type I N-Terminal Propeptide (PINP) at Month 3, 6 and 24 Endpoint	Baseline, 3, 6, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of microgram/Liter (µg/L)	LEAST_SQUARES_MEAN
SECONDARY	Percent Change From Baseline in Serum Carboxyterminal Cross-Linking Telopeptide of Type I Collagen (CTX) at Month 3, 6 and 24 Endpoint	Baseline, 3, 6, 24 months	Participants who were assigned to treatment, had non-missing baseline and at least one non-missing post-baseline measurement value.	% change of nanogram/milliliter (ng/mL)	LEAST_SQUARES_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00557310/outcomes

API reference For AI assistants